Clinical Trials
22 trialsNCT07176975 2026-05-26
A Study to Test How Well Different Doses of BI 1831169 in Combination With an Anti-PD1 Antibody Are Tolerated in Japanese People With Different Advanced Cancers
Boehringer Ingelheim
Phase 1 Not yet recruiting
NCT07606612 2026-05-26
A Study of SI-B036 in Patients With Locally Advanced or Metastatic Solid Tumors
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 1 Not yet recruiting
NCT07607054 2026-05-26
A First-in-human Phase I Study to Evaluate EMB-15 in Patients With Locally Advanced or Metastatic Solid Tumors.
Shanghai EpimAb Biotherapeutics Co., Ltd.
Phase 1 Not yet recruiting
NCT06771739 2026-05-22
A Pilot Unrestricted Payment Program for Early-stage Cancer Patients: the PAYMENT Trial
Fred Hutchinson Cancer Center
Phase NA Not yet recruiting
NCT07601243 2026-05-22
Study of GS-2426 in Participants With Advanced Solid Tumors
Gilead Sciences
Phase 1 Not yet recruiting
NCT07601334 2026-05-22
Safety and Activity of HF50 in Patients With Advanced Solid Tumors
HighField Biopharmaceuticals Corporation
Phase 1 Not yet recruiting
NCT07602855 2026-05-22
A Study of Risvutatug Rezetecan in Combination With Ivonescimab in Participants With Advanced Solid Tumors (EMBOLD PanTumour-103)
GlaxoSmithKline
Phase 1/2 Not yet recruiting
NCT07602946 2026-05-22
SELECTmeso
University of Southampton
Phase 2 Not yet recruiting
NCT07596381 2026-05-19
FAK Inhibitor in Patients With Advanced Solid Tumors
InxMed (Shanghai) Co., Ltd.
Phase 1 Not yet recruiting
NCT07592819 2026-05-18
PRODIGE 104 B
Institut Paoli-Calmettes
Phase NA Not yet recruiting
NCT07593144 2026-05-18
A Single-Arm, Open-Label Phase Ia/Ib Clinical Trial Evaluating the Safety, Tolerability, Pharmacokinetic Profile, and Preliminary Efficacy of FS-207 in Patients With Advanced Solid Tumors With High Microsatellite Instability (MSI-H)
Foresight Therapeutics (Hefei) Co., Ltd.
Phase 1 Not yet recruiting
NCT07594028 2026-05-18
Phase I/II Study of SCTB41 Plus SCTB39-1with or Without Standard Therapy in Advanced Solid Tumours
Sinocelltech Ltd.
Phase 1/2 Not yet recruiting
NCT07591155 2026-05-15
A Study of BL-ARC002 in Patients With Locally Advanced or Metastatic Solid Tumors
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 1 Not yet recruiting
NCT07591285 2026-05-15
A Study of SYS6051 in Subjects With Advanced Solid Tumors
CSPC Megalith Biopharmaceutical Co.,Ltd.
Phase 1 Not yet recruiting
NCT07586943 2026-05-14
SKB118 Injection in Advanced Solid Tumors
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Phase 1/2 Not yet recruiting
NCT07587879 2026-05-14
mRNA-LNP
IntraAb, Inc.
Phase 1/2 Not yet recruiting
NCT07582822 2026-05-13
JH021 in Patients With Advanced Solid Tumors or EGFR-Mutant NSCLC
Biotech Pharmaceutical Co., Ltd.
Phase 1 Not yet recruiting
NCT07583953 2026-05-13
An Exploratory Study of Personalized Cancer Vaccine in Adjuvant Therapy of Solid Tumors
Suzhou Abogen Biosciences Co., Ltd.
Phase EARLY_PHASE1 Not yet recruiting
NCT07545265 2026-05-08
SKB565 for Injection in Advanced Solid Tumors
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Phase 1/2 Not yet recruiting
NCT07545291 2026-05-07
A Spiritual Health Intervention (PATH) for Improving Spiritual, Religious and Emotional Distress in Cancer Patients
Fred Hutchinson Cancer Center
Phase NA Not yet recruiting
NCT07566247 2026-05-05
A Phase I Clinical Study of AK150 in Advanced Malignant Solid Tumor
Akeso
Phase 1 Not yet recruiting
NCT06895681 2026-05-04
UCSF Biobank for Hereditary Cancers and Tumor-Associated Mutations
University of California, San Francisco
Not yet recruiting